RT Journal Article SR Electronic T1 Evaluation of the number of COVID-19 undiagnosed infected using source of infection measurements JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.09.20126318 DO 10.1101/2020.06.09.20126318 A1 Melka, Akiva B A1 Louzoun, Yoram YR 2020 UL http://medrxiv.org/content/early/2020/06/15/2020.06.09.20126318.abstract AB Multiple studies have been conducted to predict the impact and duration of the current COVID-19 epidemics. Most of those studies rely on parameter calibration using the published number of confirmed cases. Unfortunately, this number is usually incomplete and biased due to the lack of testing capacities, and varying testing protocols. An essential requirement for better monitoring is the evaluation of the number of undiagnosed infected individuals. This number is crucial for the determination of transmission prevention strategies and it provides statistics on the epidemic dynamics. To estimate the number of undiagnosed infected individuals, we studied the relation between the fraction of diagnosed infected out of all infected, and the fraction of infected with known contaminator out of all diagnosed infected. We simulated multiple models currently used to study the COVID-19 pandemic and computed the relation between these two fractions in all those models. Across most models currently used and for most realistic model parameters, the relation between the two fractions is consistently linear and model independent. This relation can be used to estimate the number of undiagnosed infected, with no explicit epidemiological model. We apply this method to measure the number of undiagnosed infected in Israel. Since the fraction of confirmed cases with a known source can be obtained from epidemiological investigations in any country, one can estimate the total number of infected individuals in the same country.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDoD Grant N629091912097Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:...All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available